Beuselinck, B
Jean-Baptiste, J
Couchy, G
Job, S
De Reynies, A
Wolter, P
Théodore, C
Gravis, G
Rousseau, B
Albiges, L
Joniau, S
Verkarre, V
Lerut, E
Patard, J J
Schöffski, P
Méjean, A
Elaidi, R
Oudard, S
Zucman-Rossi, J
Article History
Revised: 27 August 2015
Accepted: 2 September 2015
First Online: 13 October 2015
Competing interests
: SO received honoraria from Takeda, Novartis, Sanofi, Astellas Roche and Bayer. PJJ received honoraria for advisory, consultant and/or educational activities from GlaxoSmithKline, Bayer, Novartis and Amgen. BB and WP are investigators of the EudraCT: 2011-006085-40/MetaSun trial supported by Pfizer. BB received honoraria for educational activities from GlaxoSmithKline and Amgen. Z-RJ received honorarium from Pfizer, Astellas, Lilly and Bayer. AL received consulting fees from Pfizer, Sanofi, Novartis and Amgen and research funding from Novartis and Pfizer. The remaining authors declare no conflict of interest.